首页> 中文期刊> 《中国药房》 >三黄肾康丸治疗大鼠慢性肾衰的实验研究

三黄肾康丸治疗大鼠慢性肾衰的实验研究

         

摘要

目的:观察三黄肾康丸对腺嘌呤致大鼠慢性肾衰(CRF)的影响。方法:连续喂养0.75%腺嘌呤使Wister大鼠产生类似于人慢性肾衰的症状。2周后,治疗组大鼠每天用中药三黄肾康丸(12.0g/kg、6.0g/kg)灌胃,连续6周,并于第4、8周测定大鼠血尿素氮(BUN)、肌酐(Scr)、RBC、HGB、HCT及肾脏病理学检查。结果:三黄肾康丸明显改善大鼠肾衰的症状,与模型组大鼠比较,肾重量减轻(P<0.01),纤维化程度降低,肾组织内结晶沉积物减少。结论:三黄肾康丸对大鼠肾衰有明显治疗效果。%OBJECTIVE: To observe the effects of SHSK on chronic renalfailure(CRF)in rats induced by adenine.METHODS: A rat model of renal failure,induced by feeding fodder containing 0.75% adenine,could manifest signs resembling those observed in man with CRF.After two weeks of adenine feeding,SHSK in a dose of 12.0g/(kg· d) or 6.0g/(kg· d) was given to the rats for six weeks.At the 4th and 8th weeks,the BUN,Scr,RBC,HGB and HCT were detected and the pathalogy of the kidney was examined.RESULTS: The results indicated that SHSK given orally could improve the signs in rats with CRF.In comparison with the untreated control group,the kidney weight was lightened(P<0.01),crystals in renal tissue decreased and the proliferation of fibroid tissue was alleviated.CONCLUSION: SHSK has a markedly therapeutic effect on renal failure in rats.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号